Coreg CR
NDC 80725-387, Carvedilol Phosphate, capsule, extended release, from Waylis Therapeutics LLC.
- Product NDC
- 80725-387
- Status
- Listed
- Labeler
- Waylis Therapeutics LLC
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022012
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/80725-387 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CARVEDILOL PHOSPHATE40 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; Adrenergic beta1-Antagonists [MoA]; Adrenergic beta2-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]; beta-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 80725-387-13 | 80725038713 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (80725-387-13) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d3625d78-6eb6-41fe-8f6f-664965c104c4
Use it
Look up 80725-387 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/80725-387 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 80725-387. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.